Chemotherapy News and Research

Latest Chemotherapy News and Research

New preclinical drug candidate shows promise in eradicating gonorrhea bacteria

A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great promise in eradicating the bacteria causing gonorrhea, according to a new publication.

23 Aug 2022

Simple computer program may help personalize cancer treatment

Cancer Council SA-funded researcher Associate Professor Stephanie Reuter Lange from UniSA hopes that a simple computer program can help personalize treatment for cancer patients.

23 Aug 2022

Modified TB vaccine could help treat non-muscle invasive bladder cancer

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

22 Aug 2022

Study gains insight into how deadliest form of brain cancer returns

The deadliest form of brain cancer returns because tumors adapt to treatment by recruiting help from nearby healthy tissue, say researchers who are trying to find a cure for the disease.

22 Aug 2022

New combination therapy shows potential to improve survival in children with neuroblastoma

Children who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival.

22 Aug 2022

Researchers reveal details of two key transition points in the development of pancreatic tumors

Pancreatic cancer has few treatment options and limited survival, with only 9% of patients still living five years after diagnosis.

22 Aug 2022

What is the impact of cannabis use in adolescence?

A new study summarized the use of cannabis among adolescents, its negative health impacts, and interventions to stop or reduce

22 Aug 2022

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

A recent article illustrated the derivation and validation of the QCOVID4 risk determination algorithm for predicting COVID-19 hospitalization and death risk in England.

18 Aug 2022

Sleepless nights over her children’s future as debts pile up

Jeni Rae Peters' budget has always been tight. But Peters, a single mom and mental health counselor, has worked to provide opportunities for her children, including two girls she adopted and a succession of foster children. One of her daughters had been homeless.

18 Aug 2022

New strategies to enhance the survival of children with neuroblastoma

Neuroblastoma, a childhood cancer that develops from neural cells on the adrenal glands, accounts for 15% of childhood cancer deaths. Almost half of children with high-risk neuroblastoma harbor extra copies of the gene MYCN (MYCN amplified), the primary driver of neuroblastoma and its resistance to therapy.

18 Aug 2022

Cancer-related fatigue contributes to balance problems following exposure to chemotherapy for breast cancer

For many women who have undergone chemotherapy for breast cancer, cancer-related fatigue (CRF) is a persistent side effect – and one that contributes to ongoing balance problems, suggests a paper in Rehabilitation Oncology, official journal of APTA Oncology, an academy of the American Physical Therapy Association (APTA).

15 Aug 2022

For medically vulnerable families, inflation’s squeeze is inescapable

Deborah Lewis rose from bed before dawn and signed in to her phone so she could begin delivering fast food, coffee, and groceries to residents in this western patch of the Mojave Desert where test pilot Chuck Yeager broke the sound barrier generations ago.

15 Aug 2022

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

Why does the risk of heart disease go up as we age? Known risk factors such as hypertension or high cholesterol don't explain all cases.

12 Aug 2022

People with blood-related cancers more likely to experience COVID breakthrough infections

Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found.

12 Aug 2022

Experts aim to relieve children from the side-effects of cancer treatments

Stopping children undergoing chemotherapy from feeling pain and other debilitating side-effects is the focus of research underway at The University of Queensland.

12 Aug 2022

OICR funding to help five research projects take the next step toward advancing cancer care

Five Ontario-based research projects will take the next step toward advancing cancer care in the province thanks to funding from the Ontario Institute for Cancer Research (OICR).

11 Aug 2022

Traditional Chinese medicine reduces severity of radiation-induced gastrointestinal mucositis in rats

For tens of thousands of Australians who receive radiotherapy as part of their cancer treatment, mucositis is a serious side effect that may cause inflammation, ulcers, diarrhea, nausea and vomiting, abdominal pain and bloating.

11 Aug 2022

Research identifies unique vulnerabilities in ALT cancers that can serve as novel therapeutic targets

In a study recently published in Cancer Research, a journal of the American Association for Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the Texas Tech University Health Sciences Center School of Medicine Cancer Center, sought to expand upon his lab's previous research that showed ALT tumors identified by a biomarker known as C-circles share a common biology that confers vulnerabilities to be exploited for cancer therapy.

10 Aug 2022

Study shows how the same protein that is key for brain development can also be the cause for the spread of cancer

Researchers at Queen's University Belfast have revealed how the pathway of an identified protein could lead to early diagnosis and targeted treatment for several cancers and brain disorders.

10 Aug 2022

Novel class of drug regresses active brain metastases in breast cancer patients

An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy drug that, according to current findings, opens up a completely new avenue in oncological research and targeted therapy.

10 Aug 2022

Chemotherapy News and Research

Latest Chemotherapy News and Research

New preclinical drug candidate shows promise in eradicating gonorrhea bacteria

Simple computer program may help personalize cancer treatment

Modified TB vaccine could help treat non-muscle invasive bladder cancer

Study gains insight into how deadliest form of brain cancer returns

New combination therapy shows potential to improve survival in children with neuroblastoma

Researchers reveal details of two key transition points in the development of pancreatic tumors

What is the impact of cannabis use in adolescence?

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

Sleepless nights over her children’s future as debts pile up

New strategies to enhance the survival of children with neuroblastoma

Cancer-related fatigue contributes to balance problems following exposure to chemotherapy for breast cancer

For medically vulnerable families, inflation’s squeeze is inescapable

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

People with blood-related cancers more likely to experience COVID breakthrough infections

Experts aim to relieve children from the side-effects of cancer treatments

OICR funding to help five research projects take the next step toward advancing cancer care

Traditional Chinese medicine reduces severity of radiation-induced gastrointestinal mucositis in rats

Research identifies unique vulnerabilities in ALT cancers that can serve as novel therapeutic targets

Study shows how the same protein that is key for brain development can also be the cause for the spread of cancer

Novel class of drug regresses active brain metastases in breast cancer patients

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in